查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370884

抗菌药敏感性测试市场 - 2018-2028 年全球产业规模、份额、趋势、竞争、机会和预测，按产品、技术、按应用、最终用户、地区和竞争细分

Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Technique, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

抗菌药物敏感性测试 (AST) 是一种实验室程序，用于确定细菌或真菌分离株对各种抗菌药物的敏感性或抗药性。体外抗菌药物敏感性测试可以使用各种类型的形式进行，例如纸片扩散、琼脂稀释、肉汤微量稀释、肉汤大量稀释和浓度梯度测试。抗菌药物敏感性测试 (AST) 的结果用于指导患者选择适当的抗菌治疗。药敏结果以最低抑菌浓度（MIC）报告，这是抑制微生物生长的抗菌剂的最低浓度。可以使用 MIC 值来确定生物体是否对抗菌剂敏感、中间或抗药性等几个特征。根据世界卫生组织（WHO）的报告，抗菌素抗药性对全球健康构成重大威胁，预计到2050年，其造成的死亡人数将超过癌症。传染患者病率的增加推动了抗菌药物敏感性测试市场的发展。由于缺乏供水、环境卫生和个人卫生，志贺氏菌、淋病奈瑟菌、脑膜炎奈瑟氏菌和伤寒沙门氏菌等几种传染病的爆发，导致预测期内对抗菌药敏感性测试的需求增加。此外，全国各地老年人口的增加以及某些类型的疾病流感、肺炎、带状疱疹和其他与老年相关的疾病预计将进一步推动全球抗菌药物敏感性测试市场的成长预测期。

传染病病率增加

传染病是由细菌、病毒、真菌、寄生虫和朊病毒等病原微生物引起的某些疾病。这些微生物可以侵入人体、繁殖并透过破坏组织、分泌毒素或引发导致发炎的免疫反应而引起疾​​病。流感、疟疾、结核病、登革热等是世界各地最常见的传染病。抗菌药物敏感性测试是确定传染病适当抗菌治疗的重要工具。当患者感染传染病时，会采集细菌样本并送往实验室进行抗菌药物敏感性测试。测试所获得的结果用于指导选择合适的抗生素来治疗患者的感染。近年来，由 SARS-CoV-2 病毒引起的 COVID-19 大流行已成为影响世界各地许多人的主要传染病。根据Worldometer 2023 年发布的报告，据观察，2021 年，美国报告了约106,771,290 例COVID-19 病例，造成1,162,471 人死亡，其次是印度报告了44,971,469 例COVID-19 人死亡，其次是印度报告了44,971,469 例COVID-19 人死亡，造成 531,692949,6949 人死亡。法国的 COVID-19 病例导致 166,811 人死亡，等等。肺炎是全世界发展中国家流行的第二常见传染病。根据联合国儿童基金会 2019 年发布的报告，肺炎导致的儿童死亡人数超过任何其他传染病，每年夺走超过 70 万名五岁以下儿童的生命，即每天约 2,000 名儿童。其中包括超过 20 万名新生儿。在全球范围内，每年每100,000 名儿童中有1,400 多例肺炎病例，即每71 名儿童中有1 例，发病率最高的地区是南亚（每100,000 名儿童2,500 例）以及西非和中非（每100,000 名儿童1,620 例）。此外，人们对预防这些疾病的抗菌药物敏感性测试的日益依赖，预计将在预测期内全球抗菌药物敏感性测试市场中出现令人印象深刻的成长。

市场概况
预测期 2024-2028
2022 年市场规模 37.6亿美元
2028 年市场规模 53.1亿美元
2023-2028 年复合年增长率 5.91%
成长最快的细分市场 医院
最大的市场 北美洲

老年人口增长

世界各地老年人口的成长也是预测期内全球抗菌药物敏感性测试市场的重要驱动因素之一。这是因为老年人更容易感染传染病，而他们的免疫系统较弱，使他们更容易受到细菌感染。医疗保健和医疗技术的进步导致老年人的预期寿命更长，从而增加了他们对抗菌药物敏感性测试的需求，以儘早阻止体内感染的发展。流感、带状疱疹、结核病、胃肠道感染和泌尿道感染是影响大多数 65 岁以后人群的疾病。根据人口资料局（PRB）根据世界上人口老化程度最高的国家发布的报告，得出的结论是，日本是世界上老龄化程度最高的国家，老年人口约占总人口的28.2%，其次是日本。义大利的老年人口占总人口的 22.8%，希腊和葡萄牙的老年人口占总人口的 21.8%，德国的老年人口占总人口的 21.4%。今后，全球各发展中国家老年人口比例的不断上升以及与老年相关疾病的盛行率不断上升，预计也将在未来几年推动全球抗菌药物敏感性测试市场的成长。

市场区隔

全球抗菌药物敏感性测试市场根据产品、技术、应用、最终用户、公司和地区进行细分。从产品来看，药敏测试市场分为手动测试（MI​​C试纸、药敏测试盘、药敏板）、自动化仪器、耗材及介质。根据技术，全球抗菌药物敏感性测试市场分为自动化 AST、Etest 方法、稀释法、纸片扩散法等。在此基础上，应用市场分为药物开发、药敏测试等。根据最终用户，全球抗菌药物敏感性测试市场分为医院、诊断实验室、生物技术和製药公司等。

市场参与者

Bio-Rad Laboratories Inc.、Thermo Fisher Scientific Inc.、丹纳赫公司、bioMerieux, Inc.、Creative Diagnostics、Hi-Media Laboratories Pvt. Ltd.、PerkinElmer, Inc.、ELITech Group SAS、F. Hoffmann-La Roche Ltd. 和 Accelerate Diagnostics, Inc. 是全球抗菌药物敏感性测试市场的一些主要参与者。

报告范围：

在本报告中，除了以下详细介绍的产业趋势外，全球抗菌药物敏感性测试市场还分为以下几类。

抗菌药物敏感性测试市场，按产品：

  • 手动测试（MI​​C 试纸、药敏测试盘、药敏板）
  • 自动化仪器
  • 耗材和媒体

抗菌药物敏感性测试市场（按技术）：

  • 自动化 AST
  • 测试方法
  • 稀释
  • 圆盘扩散
  • 其他的

抗菌药物敏感性测试市场，按应用：

  • 药物开发
  • 药敏试验
  • 其他的

抗菌药物敏感性测试市场，按最终用户划分：

  • 医院
  • 诊断实验室
  • 生技与製药公司
  • 其他的

抗菌药物敏感性测试市场，按地区：

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 亚太
  • 中国
  • 印度
  • 韩国
  • 澳洲
  • 日本
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

竞争格局

  • 公司简介：全球抗菌药物敏感性测试市场主要公司的详细分析。

可用的客製化：

  • 根据给定的市场资料，TechSci Research 可根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球抗菌药物敏感性测试市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 依产品（手动测试、（MIC 试纸条、磁敏测试盘、磁敏板）自动化仪器、耗材和介质）
    • 依技术（自动 AST、Etest 方法、稀释、纸片扩散、其他）
    • 按应用（药物开发、药敏试验、其他）
    • 按最终用户（医院、诊断实验室、生物技术和製药公司、其他）
    • 按地区
    • 按公司划分 (2022)
  • 产品市场地图

第 6 章：北美抗菌药物敏感性测试市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依技术
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲抗菌药物敏感性测试市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依技术
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区抗菌药物敏感性测试市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依技术
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第 9 章：南美洲抗菌药物敏感性测试市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依技术
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲抗菌药物敏感性测试市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依技术
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非抗菌药物敏感性测试
    • 沙乌地阿拉伯抗菌药物敏感性测试
    • 阿联酋抗菌药物敏感性测试

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

第 13 章：大环境分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 公司概况
  • 产品与服务
  • 财务（上市公司）
  • 最近的发展
  • SWOT分析
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • bioMerieux, Inc.
    • Creative Diagnostics
    • Hi-Media Laboratories Pvt. Ltd.
    • PerkinElmer, Inc.
    • ELITech Group SAS
    • F. Hoffmann-La Roche Ltd.
    • Accelerate Diagnostics, Inc.

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 15570

Antimicrobial susceptibility testing (AST) is a laboratory procedure used to determine the susceptibility or resistance of a bacterial or fungal isolate to various antimicrobial agents. In-vitro antimicrobial susceptibility testing can be performed using various type of formats such as disk diffusion, agar dilution, broth microdilution, broth macrodilution, and a concentration gradient test. The results of Antimicrobial Susceptibility Testing (AST) are used to guide the choice of appropriate antimicrobial therapy for the patient. Susceptibility results are reported as the minimum inhibitory concentration (MIC), which is the lowest concentration of the antimicrobial agent that inhibits the growth of the organism. Several characteristics such as whether the organism is susceptible, intermediate, or resistant to the antimicrobial agent can be determined using MIC values. According to a report by the World Health Organization (WHO), antimicrobial resistance is a significant threat to global health, and it is estimated that by 2050, it could cause more deaths than cancer. The market for antimicrobial susceptibility testing is driven by the increase in prevalence of infectious diseases. Several infectious disease outbreaks such as Shigella, Neisseria gonorrhoeae, Neisseria meningitides, and Salmonella serotype typhi which has been attributed to lack of water supply, sanitation, and hygiene are rising the demand for antimicrobial susceptibility testing in the forecast period. Moreover, increase in geriatric population across various parts of the country along with certain type of diseases influenza, pneumonia, shingles, and others which are associated with them in their elder age is further expected to propel the growth of global antimicrobial susceptibility testing market in the forecast period.

Increase in Prevalence of Infectious Diseases

Infectious diseases are certain kind of disorders caused by pathogenic microorganisms, such as bacteria, viruses, fungi, parasites, and prions. These microorganisms can invade the human body, multiply, and cause disease by damaging tissues, secreting toxins, or triggering an immune response that results in inflammation. Influenza, malaria, tuberculosis, dengue, and others are some of the most commonly prevailing infectious diseases across the world. Antimicrobial susceptibility testing is a critical tool for determining the appropriate antimicrobial therapy for infectious diseases. When a patient gets affected with infectious disease, sample of the bacteria is taken and is sent to the laboratory for antimicrobial susceptibility testing. Results obtained from the test are used to guide the selection of an appropriate antibiotic for treating the patient's infection. In recent times, COVID-19 pandemic caused by the SARS-CoV-2 virus have emerged as the leading infectious disease affecting many people across the world. According to the report published by Worldometer in 2023, it has been observed that in 2021 around 106,771,290 cases of COVID-19 were reported in United States of America causing 1,162,471 deaths, followed by 44,971,469 cases of COVID-19 in India causing 531,692 deaths, 40,021,949 cases of COVID-19 in France leading to 166,811 deaths, and so on. Pneumonia is the second most common infectious diseases prevailing in various developing countries across the world. As per the report presented by UNICEF in 2019, it has been concluded that pneumonia kills more children than any other infectious disease, claiming the lives of over 700,000 children under five every year, or around 2,000 every day. This includes over 200,000 newborns. Globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children). Moreover, growing dependence of people on antimicrobial susceptibility testing for prevention of these diseases is further expected to register an impressive growth to global antimicrobial susceptibility testing market in the forecast period.

Market Overview
Forecast Period2024-2028
Market Size 2022USD3.76 Billion
Market Size 2028USD5.31 Billion
CAGR 2023-20285.91%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Growth in Geriatric Population

Growth in geriatric population across various parts of the world is also one of the significant drivers of global antimicrobial susceptibility testing market in the forecast period. This is because the elderly population is more vulnerable to infectious diseases, and their weakened immune systems make them more susceptible to bacterial infections. Improvement in healthcare and medical technology have led to longer life expectancies among geriatric people which is thereby growing the demand of antimicrobial susceptibility testing among them to stop the development of infection in their body at early stage. Influenza, shingles, tuberculosis, gastrointestinal infections, and urinary tract infections are some of the diseases which effects most of the people after 65 years of age. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population. Henceforth, growing ratio of geriatric population in various developing countries across the globe and growing prevalence of diseases associated with people during their elder age is also expected to bolster the growth of global antimicrobial susceptibility testing market in upcoming years.

Market Segmentation

The global antimicrobial susceptibility testing market is segmented based on product, technique, application, end user, company, and region. In terms of product, the antimicrobial susceptibility testing market is categorized into manual tests, (MIC strips, susceptibility testing disks, susceptibility plates), automated instruments, and consumables & media. Based on technique, global antimicrobial susceptibility testing market is fragmented into automated AST, Etest method, dilution, disk diffusion, and others. Based on, application market is segmented into drug development, susceptibility testing, and others. Based on end user, global antimicrobial susceptibility testing market is fragmented into hospitals, diagnostic laboratories, biotechnique & pharmaceutical companies, and others.

Market Players

Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, bioMerieux, Inc., Creative Diagnostics, Hi-Media Laboratories Pvt. Ltd., PerkinElmer, Inc., ELITech Group SAS, F. Hoffmann-La Roche Ltd., and Accelerate Diagnostics, Inc. are some of the key players in the global antimicrobial susceptibility testing market.

Report Scope:

In this report, global antimicrobial susceptibility testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below.

Antimicrobial Susceptibility Testing Market, By Product:

  • Manual Tests (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates)
  • Automated Instruments
  • Consumables & Media

Antimicrobial Susceptibility Testing Market, By Technique:

  • Automated AST
  • Etest Method
  • Dilution
  • Disk Diffusion
  • Others

Antimicrobial Susceptibility Testing Market, By Application:

  • Drug Development
  • Susceptibility Testing
  • Others

Antimicrobial Susceptibility Testing Market, By End User:

  • Hospitals
  • Diagnostic Laboratories
  • BioTechnique & Pharmaceutical Companies
  • Others

Antimicrobial Susceptibility Testing Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in global antimicrobial susceptibility testing market.

Available Customizations:

  • With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Antimicrobial Susceptibility Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Manual Tests, (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates) Automated Instruments, Consumables & Media)
    • 5.2.2. By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, Others)
    • 5.2.3. By Application (Drug Development, Susceptibility Testing, Others)
    • 5.2.4. By End User (Hospitals, Diagnostic Laboratories, BioTechnique & Pharmaceutical Companies, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Market Map

6. North America Antimicrobial Susceptibility Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Antimicrobial Susceptibility Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3 Europe: Country Analysis
    • 7.3.1. France Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Antimicrobial Susceptibility Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Bio-Rad Laboratories Inc.
    • 15.6.2. Thermo Fisher Scientific Inc.
    • 15.6.3. Danaher Corporation
    • 15.6.4. bioMerieux, Inc.
    • 15.6.5. Creative Diagnostics
    • 15.6.6. Hi-Media Laboratories Pvt. Ltd.
    • 15.6.7. PerkinElmer, Inc.
    • 15.6.8. ELITech Group SAS
    • 15.6.9. F. Hoffmann-La Roche Ltd.
    • 15.6.10. Accelerate Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer